Ludwig-Maximilians-Universität München Kum

München

0 studies enrolling now · 1 studies all time

What they study most

Cholangiocarcinoma

Studies at this site

• Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma — Running, not enrolling